Kunming Chuan Jin Nuo Chemical Co., Ltd. (SHE:300505)
China · Delayed Price · Currency is CNY 27.78
+0.46 (1.68%)
Feb 6, 2026, 3:08 PM CST
SHE:300505 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 3,800 | 3,193 | 2,696 | 2,518 | 1,536 | 1,047 |
Other Revenue | 14.32 | 14.32 | 15.02 | 1.43 | - | 2.53 |
| 3,814 | 3,207 | 2,711 | 2,520 | 1,536 | 1,050 | |
Revenue Growth (YoY) | 27.28% | 18.30% | 7.60% | 64.07% | 46.30% | -6.77% |
Cost of Revenue | 3,156 | 2,784 | 2,678 | 1,995 | 1,220 | 957.73 |
Gross Profit | 658.39 | 423.16 | 33.31 | 524.95 | 315.9 | 92.08 |
Selling, General & Admin | 168.32 | 137.84 | 100.99 | 92.47 | 72.12 | 41 |
Research & Development | 29.85 | 50.54 | 42.62 | 9.74 | 3.25 | 2.54 |
Other Operating Expenses | 18.3 | 1.11 | 1.56 | 6.48 | 0.57 | -9.9 |
Operating Expenses | 216.97 | 188.87 | 147.06 | 108.67 | 76.17 | 31.71 |
Operating Income | 441.42 | 234.29 | -113.75 | 416.29 | 239.73 | 60.37 |
Interest Expense | -18.74 | -21.4 | -35.02 | -16.62 | -16.82 | -9.46 |
Interest & Investment Income | 9.44 | 11.36 | 8.79 | 0.66 | 0.7 | 0.52 |
Currency Exchange Gain (Loss) | 5.57 | 5.57 | 0.55 | 5.4 | -0.51 | -2.45 |
Other Non Operating Income (Expenses) | -14.59 | -18.84 | -5.47 | -3.85 | 0.49 | 2.28 |
EBT Excluding Unusual Items | 423.1 | 210.98 | -144.9 | 401.87 | 223.58 | 51.27 |
Gain (Loss) on Sale of Investments | -0.37 | -0.37 | - | - | - | - |
Gain (Loss) on Sale of Assets | 0 | 0 | 0.05 | -0.07 | -0.09 | -0.03 |
Asset Writedown | -1.52 | -3.9 | -0.27 | - | -0.18 | -1.9 |
Other Unusual Items | 21.32 | 10.09 | 11.85 | 11.19 | - | - |
Pretax Income | 442.54 | 216.79 | -133.27 | 412.99 | 223.31 | 49.33 |
Income Tax Expense | 53.17 | 31.4 | -34.81 | 50.89 | 29.23 | 8.02 |
Earnings From Continuing Operations | 389.36 | 185.39 | -98.47 | 362.11 | 194.08 | 41.32 |
Minority Interest in Earnings | -19.34 | -9.34 | 7.01 | -15.06 | -5.02 | 0.16 |
Net Income | 370.02 | 176.06 | -91.46 | 347.04 | 189.07 | 41.48 |
Net Income to Common | 370.02 | 176.06 | -91.46 | 347.04 | 189.07 | 41.48 |
Net Income Growth | 191.16% | - | - | 83.56% | 355.83% | -43.04% |
Shares Outstanding (Basic) | 275 | 275 | 246 | 225 | 200 | 195 |
Shares Outstanding (Diluted) | 275 | 275 | 246 | 225 | 200 | 195 |
Shares Change (YoY) | -0.01% | 11.92% | 9.30% | 12.19% | 2.51% | 0.59% |
EPS (Basic) | 1.35 | 0.64 | -0.37 | 1.54 | 0.94 | 0.21 |
EPS (Diluted) | 1.35 | 0.64 | -0.37 | 1.54 | 0.94 | 0.21 |
EPS Growth | 191.19% | - | - | 63.61% | 344.65% | -43.37% |
Free Cash Flow | 60.76 | 71.69 | -65.41 | -150.14 | -220.17 | -199.67 |
Free Cash Flow Per Share | 0.22 | 0.26 | -0.27 | -0.67 | -1.10 | -1.02 |
Dividend Per Share | 0.300 | 0.300 | 0.110 | - | 0.133 | 0.043 |
Dividend Growth | 172.73% | 172.73% | - | - | 207.85% | -47.26% |
Gross Margin | 17.26% | 13.19% | 1.23% | 20.83% | 20.57% | 8.77% |
Operating Margin | 11.57% | 7.31% | -4.20% | 16.52% | 15.61% | 5.75% |
Profit Margin | 9.70% | 5.49% | -3.37% | 13.77% | 12.31% | 3.95% |
Free Cash Flow Margin | 1.59% | 2.23% | -2.41% | -5.96% | -14.34% | -19.02% |
EBITDA | 597.82 | 380.37 | 18.54 | 527.5 | 326.13 | 123.32 |
EBITDA Margin | 15.67% | 11.86% | 0.68% | 20.93% | 21.23% | 11.75% |
D&A For EBITDA | 156.4 | 146.07 | 132.3 | 111.21 | 86.41 | 62.95 |
EBIT | 441.42 | 234.29 | -113.75 | 416.29 | 239.73 | 60.37 |
EBIT Margin | 11.57% | 7.31% | -4.20% | 16.52% | 15.61% | 5.75% |
Effective Tax Rate | 12.02% | 14.48% | - | 12.32% | 13.09% | 16.25% |
Revenue as Reported | 3,814 | 3,207 | 2,711 | 2,520 | 1,536 | 1,050 |
Advertising Expenses | - | 1.22 | 0.81 | 0.12 | 0.21 | 0.18 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.